| Introduction | For Patients | For Science | For Society | Looking Ahead Through its long-standing partnership with the World Federation of Hemophilia (WFH) Humanitarian Aid Program, CSL Behring is supporting efforts to strengthen haemophilia communities in countries where significant gaps remain. Through engagement with patients, clinicians, patient organisations and health authorities, CSL Behring and WFH support education, advocacy and local capability. This helps communities build greater knowledge and capacity around haemophilia. Recent field visits to Morocco and Uzbekistan with WFH reinforced the importance of this approach. As CSL’s Senior Director, Head of Global Patient Advocacy and Policy, Dr Sujan Sivasubramaniyam, explains: “Humanitarian aid can be a bridge to lasting progress – providing vital support today, while partnerships help strengthen health systems and build local capability for the future.” Supporting the Next Generation of Bleeding Disorders Research For more than 40 years, the Professor Heimburger Award has recognised outstanding early-career researchers dedicated to advancing care for people with bleeding disorders. In 2025, five researchers across leading European universities and medical centres received a €25,000 EUR research grant from CSL, including Sophie Hordijk, a PhD candidate at Erasmus Medical Center in the Netherlands. Sophie’s research focuses on uncovering the biological mechanisms that drive gastrointestinal bleeding in people with von Willebrand disease. By deepening scientific understanding of this serious condition, her work aims to identify new therapeutic targets that could lead to additional treatment options. By supporting emerging researchers like Sophie, the Professor Heimburger Award helps accelerate scientific discoveries and foster innovation with the potential to improve outcomes for people with bleeding disorders worldwide. Partnering With the World Federation of Hemophilia 16 | CSL IMPACT REPORT 2026
RkJQdWJsaXNoZXIy MjE2NDg3